Healthcare Services Group, Inc (NASDAQ: HCSG) on Friday, plunged -1.19% from the previous trading day, before settling in for the closing price of $19.32. Within the past 52 weeks, HCSG’s price has moved between $9.12 and $20.26.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -9.23%. The company achieved an average annual earnings per share of 51.24%. With a float of $69.71 million, this company’s outstanding shares have now reached $70.67 million.
Healthcare Services Group, Inc (HCSG) Insider Updates
Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of Healthcare Services Group, Inc is 1.06%, while institutional ownership is 103.94%. The most recent insider transaction that took place on Oct 28 ’25, was worth 547,270. Before that another transaction happened on Oct 27 ’25, when Company’s Officer proposed sale 20,996 for $19.04, making the entire transaction worth $399,749.
Healthcare Services Group, Inc (HCSG) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.16 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.2) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.69% during the next five years compared to -9.23% drop over the previous five years of trading.
Healthcare Services Group, Inc (NASDAQ: HCSG) Trading Performance Indicators
Healthcare Services Group, Inc (HCSG) is currently performing well based on its current performance indicators. A quick ratio of 2.88 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.74. Likewise, its price to free cash flow for the trailing twelve months is 8.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.54, a number that is poised to hit 0.22 in the next quarter and is forecasted to reach 0.96 in one year’s time.
